Kindred Biosciences (KIN) Misses Q4 EPS by 4c

Kindred Biosciences (NASDAQ: KIN) reported Q4 EPS of ($0.35), $0.04 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance